Cargando…
Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions
Since its first introduction, levodopa has become the cornerstone for the treatment of Parkinson’s disease and remains the leading therapeutic choice for motor control therapy so far. Unfortunately, the subsequent appearance of abnormal involuntary movements, known as dyskinesias, is a frequent draw...
Autores principales: | di Biase, Lazzaro, Pecoraro, Pasquale Maria, Carbone, Simona Paola, Caminiti, Maria Letizia, Di Lazzaro, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342913/ https://www.ncbi.nlm.nih.gov/pubmed/37445461 http://dx.doi.org/10.3390/jcm12134427 |
Ejemplares similares
-
Quantitative High Density EEG Brain Connectivity Evaluation in Parkinson’s Disease: The Phase Locking Value (PLV)
por: di Biase, Lazzaro, et al.
Publicado: (2023) -
Parkinson’s Disease Wearable Gait Analysis: Kinematic and Dynamic Markers for Diagnosis
por: di Biase, Lazzaro, et al.
Publicado: (2022) -
Dystonia Diagnosis: Clinical Neurophysiology and Genetics
por: di Biase, Lazzaro, et al.
Publicado: (2022) -
Markerless Radio Frequency Indoor Monitoring for Telemedicine: Gait Analysis, Indoor Positioning, Fall Detection, Tremor Analysis, Vital Signs and Sleep Monitoring
por: di Biase, Lazzaro, et al.
Publicado: (2022) -
Neurophysiology tools to lower the stroke onset to treatment time during the golden hour: microwaves, bioelectrical impedance and near infrared spectroscopy
por: di Biase, Lazzaro, et al.
Publicado: (2022)